一个基于生理学的药理动力学/药理动力学 (PBPK/PD) 模型,用于杀虫剂二甲酸
Richard Reiss1, Anne Loccisano1, Andrew Deines2
1Exponent, Alexandria, VA, USA.
Xenobiotica; the fate of foreign compounds in biological systems
|September 14, 2023
概括
对有机酸盐杀虫剂二甲酸盐及其活性代谢物甲酸盐 (omethoate) 进行了生理基础的药理动力学/药理动力学 (PBPK/PD) 模型的开发. 这些模型准确地预测了大鼠和人类的乙胆酶 (AChE) 抑制,有助于风险评估.
科学领域:
- 毒理学 毒理学 毒理学
- 药理动力学 药理动力学
- 药理动力学是什么 药理动力学
- 计算建模 计算建模
背景情况:
- 狄米酸盐是一种有机酸盐杀虫剂,通过代谢转化为欧米酸盐,这是主要的毒剂.
- 欧美酸抑制红细胞 (RBC) 和大脑中的乙胆酶 (AChE),导致毒性.
- 准确的建模对于了解二甲酸盐的毒动力学和风险评估至关重要.
研究的目的:
- 开发基于生理学的二甲酸盐和甲酸盐的药理动力学/药理动力学 (PBPK/PD) 模型.
- 模拟二甲酸盐和甲酸盐的吸收,分布,新陈代谢,分泌和ACHE抑制.
- 建立一个人类模型来估计出发点 (POD) 进行风险评估和减少不确定性因素.
主要方法:
- 对成年和产后大鼠和人类开发PBPK/PD模型.
- 模拟二甲酸盐和甲酸盐的动力学,包括转化,新陈代谢和分泌.
- 评估大鼠模型与广泛的体内血液度和ACHE抑制数据的对比.
主要成果:
- 经过验证的老鼠PBPK/PD模型通过灵敏度分析证明了稳定性.
- 开发的人类PBPK/PD模型准确地纳入了人类特定的参数.
- 人类模型的应用使得对风险评估的PODs的估计成为可能.
结论:
- 开发的PBPK/PD模型为了解二甲酸盐和甲酸盐毒动力学提供了一个强大的框架.
- 人类模型通过将物种间不确定性因子从10X降低到1X,促进了更准确的风险评估.
- 这种建模方法增强了关于二甲酸盐暴露的监管决策的科学基础.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Model Approaches for Pharmacokinetic Data: Physiological Models
72
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
72
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Pharmacokinetic Models: Overview
770
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
770
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
115
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
115
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96


